ProStrakan agrees Japanese takeover

&Tab;&Tab;<div class&equals;"wpcnt">&NewLine;&Tab;&Tab;&Tab;<div class&equals;"wpa">&NewLine;&Tab;&Tab;&Tab;&Tab;<span class&equals;"wpa-about">Advertisements<&sol;span>&NewLine;&Tab;&Tab;&Tab;&Tab;<div class&equals;"u top&lowbar;amp">&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;<amp-ad width&equals;"300" height&equals;"265"&NewLine;&Tab;&Tab; type&equals;"pubmine"&NewLine;&Tab;&Tab; data-siteid&equals;"111265417"&NewLine;&Tab;&Tab; data-section&equals;"2">&NewLine;&Tab;&Tab;<&sol;amp-ad>&NewLine;&Tab;&Tab;&Tab;&Tab;<&sol;div>&NewLine;&Tab;&Tab;&Tab;<&sol;div>&NewLine;&Tab;&Tab;<&sol;div><p><a href&equals;"http&colon;&sol;&sol;londonglossy&period;com&sol;wp-content&sol;uploads&sol;2011&sol;02&sol;prostrakan-agrees-japanese-takeover&period;jpg"><img class&equals;"alignnone size-full" title&equals;"A company that markets products to help cancer sufferers is being sold to a Japanese rival" src&equals;"http&colon;&sol;&sol;londonglossy&period;com&sol;wp-content&sol;uploads&sol;2011&sol;02&sol;min-prostrakan-agrees-japanese-takeover&period;jpg" alt&equals;"A company that markets products to help cancer sufferers is being sold to a Japanese rival"&sol;><&sol;a><&sol;p>&NewLine;<p>A company that markets products to help cancer sufferers is being sold to a Japanese rival for £292 million&period;<&sol;p>&NewLine;<p>Scottish bio-tech firm ProStrakan &&num;8211&semi; whose products include painkillers for cancer sufferers and patients undergoing chemotherapy in Europe and the US &&num;8211&semi; has agreed to a takeover by Japan&&num;8217&semi;s Kyowa Hakko Kirin &lpar;KHK&rpar;&period;<&sol;p>&NewLine;<p>News of the offer&comma; which values the company at 41&percnt; more than before buy-out talks began&comma; saw shares rocket 20&percnt;&period;<&sol;p>&NewLine;<p>KHK&comma; which has already won the approval from institutional backers who hold more than 47&percnt; of the shares&comma; said the acquisition would provide it with a sales platform in Europe and the US that it could use to sell its own products&comma; including therapeutic antibodies&period;<&sol;p>&NewLine;<p>ProStrakan employs between 60 and 70 staff at its head office in Galashiels in the Scottish Borders and an additional 50 staff across the UK&comma; with others in America and Europe&period;<&sol;p>&NewLine;<p>A ProStrakan spokesman said he is optimistic KHK would retain the company&&num;8217&semi;s 300 employees&period;<&sol;p>&NewLine;<p>Its best known products include Abstral&comma; a fast-acting painkilling tablet for cancer sufferers&comma; and Sancuso&comma; a drug that helps stop patients undergoing chemotherapy suffering from nausea and vomiting&period;<&sol;p>&NewLine;<p>Peter Allen&comma; chairman and acting chief executive of ProStrakan&comma; said&colon; &&num;8220&semi;The fit between ProStrakan and KHK is unmistakable in terms of products&comma; geography and infrastructure&period;<&sol;p>&NewLine;<p>&&num;8220&semi;We are enthused by KHK&&num;8217&semi;s plans for the business and&comma; in particular&comma; with its intentions regarding ProStrakan&&num;8217&semi;s infrastructure in Europe and the US&comma;&&num;8221&semi; he added&period;<&sol;p>&NewLine;&Tab;&Tab;&Tab;<div style&equals;"padding-bottom&colon;15px&semi;" class&equals;"wordads-tag" data-slot-type&equals;"belowpost">&NewLine;&Tab;&Tab;&Tab;&Tab;<div id&equals;"atatags-dynamic-belowpost-69e2dc53a8973">&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;<script type&equals;"text&sol;javascript">&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;window&period;getAdSnippetCallback &equals; function &lpar;&rpar; &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;if &lpar; false &equals;&equals;&equals; &lpar; window&period;isWatlV1 &quest;&quest; false &rpar; &rpar; &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&sol;&sol; Use Aditude scripts&period;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;window&period;tudeMappings &equals; window&period;tudeMappings &vert;&vert; &lbrack;&rsqb;&semi;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;window&period;tudeMappings&period;push&lpar; &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;divId&colon; 'atatags-dynamic-belowpost-69e2dc53a8973'&comma;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;format&colon; 'belowpost'&comma;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub; &rpar;&semi;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub;&NewLine;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;if &lpar; document&period;readyState &equals;&equals;&equals; 'loading' &rpar; &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;document&period;addEventListener&lpar; 'DOMContentLoaded'&comma; window&period;getAdSnippetCallback &rpar;&semi;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub; else &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;window&period;getAdSnippetCallback&lpar;&rpar;&semi;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;<&sol;script>&NewLine;&Tab;&Tab;&Tab;&Tab;<&sol;div>&NewLine;&Tab;&Tab;&Tab;<&sol;div>


Discover more from London Glossy Post

Subscribe to get the latest posts sent to your email.

- Advertisement -